Status:

RECRUITING

Optimised Decrement Evoked Potential (DeEP) Mapping to Guide Ventricular Tachycardia (VT) Ablation in Patients With Structural Heart Disease VT

Lead Sponsor:

University Hospitals Coventry and Warwickshire NHS Trust

Conditions:

Structural Heart Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Ventricular tachycardia (VT) is a life-threatening heart rhythm disorder. Special pacemakers called implantable cardiac defibrillators (ICDs) help treat VT episodes, however they do not prevent the VT...

Eligibility Criteria

Inclusion

  • ≥18 years old
  • Patients with an implantable cardioverter defibrillator (ICD)
  • Eligible for VT ablation as part of standard care (urgent or elective)
  • Ischaemic heart disease and prior myocardial infarction (MI) (using the international definition of MI: Q waves or imaging evidence of regional myocardial akinesis/thinning in the absence of a non-ischemic cause with documentation of prior ischaemic injury) OR other structural heart disease (such as: arrhythmogenic cardiomyopathy (ACM), or dilated cardiomyopathy (DCM), or hypertrophic cardiomyopathy (HCM), or sarcoidosis, or myocarditis).

Exclusion

  • Lacks capacity to provide informed consent
  • New York Heart Association (NYHA) class IV heart failure
  • Life expectancy of less than 12 months
  • Implanted with a ventricular assist device
  • Presence of mobile intracardiac thrombus
  • Reversible cause of VT
  • Women who are pregnant or nursing
  • Both mechanical aortic and mitral valves
  • Enrolment in a concurrent interventional clinical study that in the judgement of the investigator would increase risk to the patient or deem the patient inappropriate to participate in this study.

Key Trial Info

Start Date :

April 11 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 3 2027

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT06937983

Start Date

April 11 2025

End Date

December 3 2027

Last Update

April 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals Coventry & Warwickshire NHS Trust

Coventry, West Midlands, United Kingdom, CV2 2DX

Optimised Decrement Evoked Potential (DeEP) Mapping to Guide Ventricular Tachycardia (VT) Ablation in Patients With Structural Heart Disease VT | DecenTrialz